Navigation Links
Action-Filled Video Games Boost Adult Vision
Date:3/30/2009

And the benefits can last for years, researchers say

MONDAY, March 30 (HealthDay News) Action video games aren't just child's play: A new study finds the pastime can help adults improve a part of eyesight called contrast sensitivity, one of the first parts of vision to be affected by aging.

Contrast sensitivity -- the ability to notice even minor changes in shades of grey against a uniform background -- is important in situations such as driving at night or in poor visibility, according to background information in the study. Contrast sensitivity can be improved through surgery, glasses or contact lenses.

But this study suggests video games may also improve contrast sensitivity. Daphne Bavelier and colleagues at the University of Rochester found that expert video game players who played action games had better contrast sensitivity than those who played non-action games.

To test whether this was simply because people with better contrast sensitivity were more likely to play action games, the researchers gave the non-action players intensive practice in action games. This led to improved contrast sensitivity.

The improvements lasted for months or even years. The findings suggest that time spent in front of a computer isn't necessarily harmful, as has been suggested, the researchers said.

The study was published online in the journal Nature Neuroscience.

More information

The U.S. National Institute on Aging has more about aging and your eyes.



-- Robert Preidt



SOURCE: Nature Research Journals, news release, March 29, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Action video games improve vision
2. Video: CRESTOR(R) Reduced Risk of Blood Clots in the Veins
3. Video: Celebrities and Thousands of Walkers Unite at Nations Capitol to Raise Awareness About Seizures and Epilepsy
4. Scientists Capture HIV Transfer Among T-Cells on Video
5. HB Litigation Conferences LLC: Video of Much-Discussed Asbestos Litigation Debates & Discourse Now Available
6. Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing $1 Million to The Make-A-Wish Foundation(R)
7. NeuroFocus Launches NGame; New Suite of Neuromarketing Products and Services for the Videogame Industry Elite
8. Video: Cosmetic Procedures Up In All Ethnic Groups Except Caucasians In 2008
9. Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra
10. AGA Medical Corporation Launches Third Web-Based Stroke Education and Awareness Video Featuring Professional Football Player Tedy Bruschi
11. American Diabetes Association Alert(R) Day Video - Do You Have Diabetes?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Action-Filled Video Games Boost Adult Vision
Action-Filled Video Games Boost Adult Vision
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 1Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 1President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 3St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 1St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 2